Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Pharmaceuticals ETF (XPH)

40.38
Delayed Data
As of 3:59pm ET
 -1.56 / -3.72%
Today’s Change
38.28
Today|||52-Week Range
67.25
-21.13%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month-16.41% 3 years+16.72%
3 months-11.27% 5 years+16.50%
1 year-21.75% Since inception+13.44%
Data through 02/06/2016

Quote Details

Previous close$41.94
Open day’s range39.73 – 41.29
Net asset value (NAV)41.95 (02/05/2016)
Daily volume169,625
Average volume (3 months)222,319
Data as of 3:59pm ET, 02/08/2016

Peer Comparisonvs. Health ETFs

 XPHCategory
Performance 5-yr return+16.50%+20.72%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio0.891.06
Net assets$514.9M$1.4B
Average market cap$9.6B$36.5B
Average P/E27.422.4
Dividend / Share--0.22%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson4.61%
MYL Mylan NV4.50%
PRGO Perrigo Company PLC4.41%
ENDP Endo International PLC4.36%
MRK Merck4.36%
JAZZ Jazz Pharmaceuticals PLC4.30%
PCRX Pacira Pharmaceuticals Inc4.30%
PFE Pfizer4.27%
LLY Eli Lilly and Co4.26%
AGN Allergan4.22%

Partner Offers